“…Nevertheless, the effective utilization of migrasomes as biomarkers has encountered obstacles owing to the lack of straightforward capture and analysis techniques. Traditional approaches for migrasome isolation and quantification involve time‐consuming and labour‐intensive methods, such as density gradient centrifugation for purification, electron microscopy and immunofluorescence microscopy for quantification, and Western blotting or qRT‐PCR for the analysis of migrasome‐contained proteins and RNAs (Baumann, 2021; Chen et al., 2018; Cheng et al., 2022; Ding et al., 2023; Fan et al., 2022; Huang et al., 2019; Jiang et al., 2019; Liang & Yu, 2023; Liu et al., 2020; Lu et al., 2020; Ma et al., 2015; Qin et al., 2022; Saito et al., 2021; Schmidt‐Pogoda et al., 2018; Wu et al., 2022; Wu et al., 2017; Zhang et al., 2022; Zhao et al., 2019; Zhen & Stenmark, 2023; Zhu et al., 2021; Zhang et al 2022, Li et al, 2023). These methods are ill‐suited for clinical application due to their demands for substantial sample volumes, complexity, limited throughput, high costs and extended processing times.…”